Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

          
Total article views   Abstract views HTML views PDF downloads Totals
10,986 Dovepress* 10,986 0+ 2,961 10,986
Totals 10,986 0 2,961 10,986
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar